PortfoliosLab logoPortfoliosLab logo
ABM vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ABM vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ABM Industries Incorporated (ABM) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABM achieves a 15.62% return, which is significantly higher than ABBV's 12.42% return. Over the past 10 years, ABM has underperformed ABBV with an annualized return of 4.75%, while ABBV has yielded a comparatively higher 18.94% annualized return.


ABM

1D
0.65%
1M
8.27%
6M
5.53%
YTD
15.62%
1Y
6.63%
3Y*
4.13%
5Y*
2.72%
10Y*
4.75%
ALL TIME*
9.35%

ABBV

1D
-2.51%
1M
0.66%
6M
14.27%
YTD
12.42%
1Y
36.88%
3Y*
23.28%
5Y*
20.99%
10Y*
18.94%
ALL TIME*
20.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.40B$1.53B$1.60B
$20.49M$19.71M$24.71M

ABM vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ABM
ABM Industries Incorporated
15.62%-15.53%16.35%3.04%10.73%9.81%2.14%20.39%-13.05%-6.13%
ABBV
AbbVie Inc.
12.42%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between ABM and ABBV is 0.10, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.10

Correlation (3Y)
Balances recent behavior with more history.

0.17

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.19

Correlation (10Y)
Provides a long-term view across more market conditions.

0.24

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.26

The correlation between ABM and ABBV shifts across timeframes, from 0.10 (1 year) to 0.26 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ABM:

$2.81B

ABBV:

$443.24B

EPS

ABM:

$2.62

ABBV:

$2.05

PE Ratio

ABM:

18.32

ABBV:

122.29

PS Ratio

ABM:

0.32

ABBV:

7.08

PB Ratio

ABM:

1.62

ABBV:

16.19

Total Revenue (TTM)

ABM:

$9.05B

ABBV:

$62.82B

Gross Profit (TTM)

ABM:

$1.04B

ABBV:

$46.15B

EBITDA (TTM)

ABM:

$398.40M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ABM vs. ABBV — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ABM
ABM Risk / Return Rank: 5050
Overall Rank
ABM Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
ABM Sortino Ratio Rank: 4646
Sortino Ratio Rank
ABM Omega Ratio Rank: 4747
Omega Ratio Rank
ABM Calmar Ratio Rank: 5252
Calmar Ratio Rank
ABM Martin Ratio Rank: 5252
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 8181
Overall Rank
ABBV Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 8282
Sortino Ratio Rank
ABBV Omega Ratio Rank: 8080
Omega Ratio Rank
ABBV Calmar Ratio Rank: 8080
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ABM vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ABM Industries Incorporated (ABM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ABMABBVDifference
Sharpe ratioReturn per unit of total volatility

-1.18

Sortino ratioReturn per unit of downside risk

-1.63

Omega ratioGain probability vs. loss probability

1.07

1.26

-0.19

Calmar ratioReturn relative to maximum drawdown

0.28

2.14

-1.86

Martin ratioReturn relative to average drawdown

0.54

4.73

-4.19

ABM vs. ABBV - Sharpe Ratio Comparison

The current ABM Sharpe Ratio is 0.24, which is lower than the ABBV Sharpe Ratio of 1.42. The chart below compares the historical Sharpe Ratios of ABM and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ABM vs. ABBV - Drawdown Comparison

The maximum ABM drawdown since its inception was -59.64%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ABM and ABBV.


Loading charts...

Drawdown Indicators


ABMABBVDifference

Max Drawdown

Largest peak-to-trough decline

-59.64%

-45.09%

-14.55%

Max Drawdown (1Y)

Largest decline over 1 year

-23.78%

-17.32%

-6.46%

Max Drawdown (3Y)

Largest decline over 3 years

-34.37%

-20.74%

-13.63%

Max Drawdown (5Y)

Largest decline over 5 years

-34.37%

-21.92%

-12.45%

Max Drawdown (10Y)

Largest decline over 10 years

-52.00%

-45.09%

-6.91%

Current Drawdown

Current decline from peak

-14.72%

-4.69%

-10.03%

Average Drawdown

Average peak-to-trough decline

-14.83%

-10.64%

-4.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.31%

7.81%

+4.50%

Volatility

ABM vs. ABBV - Volatility Comparison

The current volatility for ABM Industries Incorporated (ABM) is 7.05%, while AbbVie Inc. (ABBV) has a volatility of 8.35%. This indicates that ABM experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABMABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.05%

8.35%

-1.30%

Volatility (6M)

Calculated over the trailing 6-month period

19.93%

19.56%

+0.37%

Volatility (1Y)

Calculated over the trailing 1-year period

27.90%

26.14%

+1.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.00%

23.46%

+7.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.90%

25.92%

+7.98%

Dividends

ABM vs. ABBV - Dividend Comparison

ABM's dividend yield for the trailing twelve months is around 2.37%, less than ABBV's 2.72% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.72%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
ABM
ABM Industries Incorporated
2.37%2.51%1.76%1.96%1.76%1.86%1.47%2.40%2.18%1.80%1.62%1.69%

Financials

ABM vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between ABM Industries Incorporated and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

ABM vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between ABM Industries Incorporated and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

ABM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, ABM Industries Incorporated reported a gross profit of 277.00M and revenue of 2.29B. Therefore, the gross margin over that period was 12.1%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

ABM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, ABM Industries Incorporated reported an operating income of 86.90M and revenue of 2.29B, resulting in an operating margin of 3.8%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

ABM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, ABM Industries Incorporated reported a net income of 43.10M and revenue of 2.29B, resulting in a net margin of 1.9%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


ABM and ABBV have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (8.35%) compared to ABM (7.05%). In terms of maximum drawdown, ABM dropped -59.64% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (1.42 vs 0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABM and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer